THE DIFFERENCE IS IN THE DATA™

Strong science, strength of process, and a sense of urgency, MMS is redefining the CRO experience. Gain new insights from our data-focused and tech-enabled team of experts.

LEARN MORE

SPONSORS TRUST MMS WITH THEIR SUBMISSIONS

Our integrated regulatory, writing, publishing, and QC teams have developed effective strategies and led data planning, summarization, and lifecycle management for 50+ marketing applications in the past 5 years.

DISCOVER MMS

MODERN FSP SOLUTIONS FOR AN EVOLVING INDUSTRY

Our FSP models are designed to be flexible and scalable, bringing expertise that will increase levels of productivity to align with your organization’s goals.

SEE KEY BENEFITS

TOGETHER TRIAL WITH EDC DATABASE DESIGNED BY MMS WINS TRIAL OF THE YEAR

The TOGETHER Trial, which uses an Electronic Data Capture (EDC) system designed, built, and maintained by MMS Holdings, won the Society for Clinical Trial’s annual Trial of the Year Award.

DATA SCIENTISTS ACHIEVING NEW LEVELS OF INSIGHT

With deep regulatory expertise, strong processes, and purpose-built, flexible technology, our data science experts work to uncover new insights on disease, compound, patient, and operational improvements.

EXPLORE OUR SOLUTIONS

A WINNING DEVELOPMENT STRATEGY

MMS provides insights into your development plans, including global strategies for expedited regulatory approval and a track record of on-time delivery utilizing our trademarked APP process.

EXPLORE OUR SOLUTIONS

Regulatory Affairs
& Operations

Data Management
& Biostatistics

Regulatory &
Medical Writing

Drug Safety &
Pharmacovigilance

Quality & Compliance
Services

Transparency
Services

Helping sponsors navigate a complex regulatory environment

MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards.

Industry experts across 4 continents are available to support your programs 24 hours a day with a 97 percent sponsor satisfaction rating

“MMS is the only company I would reach out to, big or small. MMS understood and worked within our capabilities and with our unconventional strategies we were forced into by the nature of being small and underfunded. Your team worked with us, diligently, beyond expectations, and got us over the finish line to success.” —Sr. Vice President, Research & Development, Small Pharma

“This team never stopped working towards our deadline, and from day one, we were impressed with the efficient and smart decisions brought forth by MMS to bring this drug to market.” —Randy Brenner, Senior Vice President Global Regulatory Affairs, Quality, and Technical Operations, Paratek

“We work with a lot of CROs and consultants here in Boston. They’re good, they do fine, but you guys are the standard.” — Senior Director, Clinical Quality Assurance, Large Pharma

“MMS consistently provides our team with the highest level of detail and quality work in every task that they undertake. I am pleased that we were able to attain this fast track status and look forward to working with MMS as we continue into the phase three studies.” — CEO and Head of Research and Development, Small Pharma

“The choice in collaborating with MMS to meet this milestone… was simple, given their deep scientific knowledge and strategic resource models,” — Dr. Steven Gullans, CEO, Gemphire

Latest News

Together Trial with EDC Database Designed by MMS Wins Trial of the Year. Collection.

The TOGETHER Trial, which uses an Electronic Data Capture (EDC) system designed, built, and maintained by MMS Holdings, a data-focused contract research organization (CRO), won the Society for Clinical Trial’s annual Trial of the Year Award for 2021.

Latest Webinar

Watch Our Latest Webinar on How to Submit Non-Clinical Data to CBER Using SEND: Understanding New FDA Requirements

In this webinar, a cross-functional team of statistical programmers and regulatory experts will share actionable insights to help study teams prepare for the new requirements.

View now

Featured Blog

How does the European Union Clinical Trial Information System (EU-CTIS) Affect Clinical Trial Transparency.

There are important changes in the EU-CTR, compared to EU‑CTD, that significantly impact the governance of clinical trials in the EU. This new regulation aims to improve efficiency, vigor, and transparency of clinical studies while ensuring the highest standards of safety for clinical trial participants in the EU.